KLK3 and neoplasm: While there has been significant progress in identifying circulating tumor cells and evaluating their role as a way to monitor disease activity, in the clinical setting, prostate specific antigen (PSA) serves as the main diagnostic tool, yet its limited specificity has led to many unnecessary invasive procedures [17].